Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Assistance Listings: 93.394 -- Cancer Detection and Diagnosis Research
Last Updated: December 16, 2024
Description
Eligibility
Eligible applicants
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Government
- Public and Indian housing authorities
- County governments
- Special district governments
- Federally recognized Native American tribal governments
- State governments
- City or township governments
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Business
- Small businesses
- For-profit organizations other than small businesses
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
File name | Description | Last updated |
---|---|---|
RFA-CA-25-004-Full-Announcement.html | RFA-CA-25-004 Full Announcement Text | Dec 16, 2024 04:35 PM UTC |
Link to additional information
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-004.html
Closing: October 3, 2025
Award
$300,000
Program Funding
2
Expected awards
$--
Award Minimum
$300,000
Award Maximum
Funding opportunity number:
RFA-CA-25-004
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Education
Health
Category Explanation:
History
Version:
1
Posted date:
December 16, 2024
Archive date:
November 8, 2025